Skip to content

A randomized controlled study comparing the effects of fospropofol disodium and propofol on postoperative nausea and vomiting in high-risk populations

A randomized controlled study comparing the effects of fospropofol disodium and propofol on postoperative nausea and vomiting in high-risk populations

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114542
Enrollment
Unknown
Registered
2025-12-15
Start date
2025-12-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Propofol group:Induce and maintain anesthesia using propofol
Fospropofol group:Induce and maintain anesthesia using fospropofol

Sponsors

Fudan University Affiliated Obstetrics and Gynecology Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: The patient is aged 18-50 years old, with ASA class I-II, BMI 18.5-28kg/m^2, and a high risk according to the simplified Apfel risk score. The alkaline phosphatase (ALP) value is within the normal range, and the patient is scheduled to undergo gynecological laparoscopic surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: Women who are pregnant or breastfeeding; have moderate to severe abnormalities in liver and kidney function; have heart or respiratory diseases; have a history of drug abuse or alcohol dependence; have a long-term history of taking sedatives or analgesics; are allergic to the experimental drug or have contraindications.

Design outcomes

Primary

MeasureTime frame
Incidence of nausea and vomiting 6 hours after surgery;

Secondary

MeasureTime frame
Incidence of nausea and vomiting in the post-operative recovery room;Incidence of nausea and vomiting 24 hours after surgery;

Countries

China

Contacts

Public ContactMa Li

Fudan University Affiliated Obstetrics and Gynecology Hospital

labisa123@163.com+86 182 1751 5174

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026